Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | TYMS | P04818 | 1/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4534661 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL4533111 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL2519566 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL4527282 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL4536540 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL4535332 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL2939530 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL4531743 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL20835969 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS | |
| SCHEMBL4533190 | 0.97 | TSHR (0.60) | LMNANFKB1PMP22TSHRTYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119368142-A | Zeolite molecular sieve for adsorbing and separating carbon dioxide and its preparing process | 山东科技大学 | 2025-01-28 | — | — | CN | claimed |
| CN-111635528-B | Three-dimensional network cross-linked phosphonated benzimidazole polymer proton exchange membrane and preparation method thereof | 珠海冠宇电池股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-111349239-B | Proton exchange membrane containing phosphonated hyperbranched polybenzimidazole and preparation method and application thereof | 珠海冠宇电池股份有限公司 | 2023-01-06 | — | — | CN | claimed |
| CN-111574721-B | Phosphonated polyolefin grafted benzimidazole polymer proton exchange membrane and preparation method and application thereof | 珠海冠宇电池股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-111303437-B | Phosphonated (polyolefin-g-hyperbranched polybenzimidazole) graft copolymer and preparation method and application thereof | 珠海冠宇电池股份有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-111635528-A | Three-dimensional network cross-linked phosphonated benzimidazole polymer proton exchange membrane and preparation method thereof | 珠海冠宇电池股份有限公司 | 2020-09-08 | — | — | CN | claimed |
| CN-111574721-A | Phosphonated polyolefin grafted benzimidazole polymer proton exchange membrane and preparation method and application thereof | 珠海冠宇电池股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-111349239-A | Proton exchange membrane containing phosphonated hyperbranched polybenzimidazole and preparation method and application thereof | 珠海冠宇电池有限公司 | 2020-06-30 | — | — | CN | claimed |
| CN-111303437-A | Phosphonated (polyolefin-g-hyperbranched polybenzimidazole) graft copolymer and preparation method and application thereof | 珠海冠宇电池有限公司 | 2020-06-19 | — | — | CN | claimed |
| EP-2081600-A1 | COMBINATION OF NMDA- RECEPTOR LIGAND AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2009-07-29 | — | — | EP | claimed |
| WO-2008034815-A1 | COMBINATION OF NMDA- RECEPTOR LIGAND AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2008-03-27 | — | — | WO | claimed |
| EP-0971712-A1 | COMPOSITIONS FOR THE INHIBITION OF BONE RESORPTION | Smith & Nephew plc (GB) | 2000-01-19 | — | — | EP | claimed |
| WO-1998035674-A1 | COMPOSITIONS FOR THE INHIBITION OF BONE RESORPTION | SMITH & NEPHEW PLC (GB) | 1998-08-20 | — | — | WO | claimed |
| JP-1080849-A | — | — | None | — | — | JP | disclosed |
| US-12590288-B2 | Method of treating an inflammatory disease by administering an agent which binds a surface receptor on a tuft cell that induces an ILC class 2 inflammatory response | THE BROAD INSTITUTE, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| CN-119368142-B | Zeolite molecular sieve for adsorbing and separating carbon dioxide and its preparing process | 山东科技大学 | 2025-07-08 | — | — | CN | disclosed |
| WO-1995014681-A1 | ISOXAZOLINE COMPOUNDS AS ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1995-06-01 | — | — | WO | disclosed |
| EP-0494985-A1 | A PROCESS FOR PREPARING PEROXYCARBOXYLIC ACIDS | NOVO NORDISK A/S (DK) | 1992-07-22 | — | — | EP | disclosed |
| WO-1991006574-A1 | A PROCESS FOR PREPARING PEROXYCARBOXYLIC ACIDS | NOVO NORDISK A/S (DK) | 1991-05-16 | — | — | WO | disclosed |
| JP-S6480849-A | ANALYSIS OF CHELATE AGENT | SHIMADZU CORP | 1989-03-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590288-B2 | Method of treating an inflammatory disease by administering an agent which binds a surface receptor on a tuft cell that induces an ILC class 2 inflammatory response | GPR3, GALR3, NR4A3 | LMNA 4387/4885NFKB1 1066/4885PMP22 4255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.